In this episode Dr Cohen talks about the current interventions that he sees as having the most potential but also about the need for precision medicine as there are many causes for Alzheimer's, diabetes etc. and to treat the disease we need to understand the underlying cause. This also would involve changes in the way trials are run, to be able to identify the markers appropriate for each intervention

Mitochondrial DNA variation in Alzheimer’s disease reveals a unique microprotein called SHMOOSE

https://www.nature.com/articles/s41380-022-01769-3

Professor Pinchas Cohen is the dean of the USC Leonard Davis School of Gerontology. He is a pioneer in the emerging science of mitochondria-derived peptides and their possible therapeutic benefits for diabetes, Alzheimer's and other diseases of aging, an area which remains the focus of his current research.

Mitochondria-derived peptides in aging and healthspan

https://pubmed.ncbi.nlm.nih.gov/35499074/

Dr Cohen's page at USC

https://gero.usc.edu/faculty/cohen/

The Cohen Lab

https://gero.usc.edu/labs/cohenlab/

CohBar Inc. Web site

https://www.cohbar.com/